Gelonghui, January 18, 丨 Kangchen Pharmaceutical (01681.HK) issued an announcement. Li Qian has resigned as the company's executive director, vice chairman of the board, CEO (president), member of the remuneration committee and all other positions in the group due to health reasons, with effect from January 17, 2024.
Chairman of the Board and Executive Director An Meng has been appointed as CEO (President) with effect from January 17, 2024. Effective January 17, 2024, and after Ms Lai's resignation, An Meng has been appointed as a member of the Remuneration Committee to replace Ms Lai.